Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 7, 2023
Date Accepted: Oct 3, 2023

The final, peer-reviewed published version of this preprint can be found here:

Deep Learning Analysis of COVID-19 Vaccine Hesitancy and Confidence Expressed on Twitter in 6 High-Income Countries: Longitudinal Observational Study

Zhou X, Song S, Zhang Y, Hou Z

Deep Learning Analysis of COVID-19 Vaccine Hesitancy and Confidence Expressed on Twitter in 6 High-Income Countries: Longitudinal Observational Study

J Med Internet Res 2023;25:e49753

DOI: 10.2196/49753

PMID: 37930788

PMCID: 10629504

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Deep learning prediction of COVID-19 vaccine hesitancy and confidence expressed on Twitter in six high-income countries

  • Xinyu Zhou; 
  • Suhang Song; 
  • Ying Zhang; 
  • Zhiyuan Hou

ABSTRACT

Background:

Ongoing monitor of national and sub-national trajectory of COVID-19 vaccine hesitancy could offer support in designing tailored policies on improving vaccine uptake.

Objective:

We aim to track the temporal and spatial distribution of COVID-19 vaccine hesitancy and confidence expressed on Twitter during the entire pandemic period in major English-speaking countries.

Methods:

We collected 5,257,385 English-language tweets regarding COVID-19 vaccination between January 1, 2020, and Jun 30, 2022, in six countries - the US, UK, Australia, New Zealand, Canada, and Ireland. Transformer-based deep learning models were developed to classify each tweet as intent to accept or reject COVID-19 vaccination, and belief that COVID-19 vaccine is effective or unsafe. Socio-demographic factors associated with COVID-19 vaccine hesitancy and confidence in the US were analyzed using bivariate and multivariable linear regressions.

Results:

The six countries experienced similar evolving trends of COVID-19 vaccine hesitancy and confidence. On average, the prevalence of intent to accept COVID-19 vaccination decreased from 71.38% in March 2020 to 34.85% in June 2022 with fluctuations. The prevalence of believing COVID-19 vaccine unsafe continuously rose by 7.49 times from March 2020 (2.84%) to June 2022 (21.27%). The COVID-19 vaccine hesitancy and confidence varied by country, vaccine manufacturer, and states within a country. Democrat party and higher vaccine confidence were significantly associated with lower vaccine hesitancy across the US states.

Conclusions:

The COVID-19 vaccine hesitancy and confidence evolved and were influenced by the development of vaccines and virus during the pandemic. Large-scale self-generated discourses on social media and deep learning model provide a cost-efficient approach to monitor routine vaccine hesitancy.


 Citation

Please cite as:

Zhou X, Song S, Zhang Y, Hou Z

Deep Learning Analysis of COVID-19 Vaccine Hesitancy and Confidence Expressed on Twitter in 6 High-Income Countries: Longitudinal Observational Study

J Med Internet Res 2023;25:e49753

DOI: 10.2196/49753

PMID: 37930788

PMCID: 10629504

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.